Our globally renowned Venture Capital & Emerging Growth Companies team empowers clients throughout the development cycle—from ideation to creation, capitalization, implementation, commercialization, and monetization.
We are nationally and globally renowned for our high quality, responsive, pragmatic representation of, and committed passionate service to, entrepreneurial, tech, tech-enabled and life sciences enterprises and the investors who support them. We have a compelling value proposition comprised of experienced, problem-solving lawyers, a sensible fee structure, unique delivery model, a national network and a league-table leading reputation. PitchBook lists us among the most active law firms in this space, placing us in the top 10 law firms globally in several distinct categories.
We know the investment community, regularly representing both institutional and private investors in all kinds of equity and debt financing transactions for tech and tech-enabled, life sciences and entrepreneurial enterprises, from pre-seed, to seed to early stage to expansion and growth stage financings. Our investor-side practice includes venture capital funds, family offices, investment banks, private equity funds, hedge funds, individual angels, angel networks and angel funds.
Our financing transactional experience includes all forms of transactions from startup to IPO and beyond, including Simple Agreement for Future Equity (SAFE), Keep It Simple Securities (KISS), Convertible Notes, and priced equity transactions—from friends and family transactions to institutional investors, and from series pre-seed transactions to transactions for fully mature companies. We are on the cutting edge of transactions involving blockchain, smart contracts and digital currencies—including Simple Agreements for Future Tokens (SAFTs), security token offerings (STOs), and other emerging fintech products and solutions—representing issuers and investors. An example of our work, McCarter was the first firm to recommend Regulation A+ as mechanism for undertaking SEC-compliant STOs, now generally recognized as the preferred alternative in most cases.
For five consecutive years and 24 consecutive quarters, McCarter has been ranked near the top of the leaderboard in venture capital transactions. According to PitchBook’s global league rankings for the third quarter of 2020, McCarter ranks:
- 7th in the world in early stage financing
- 8th in the mid-Atlantic region
- 6th in the Southern region
- 9th in the Mountain region
- 11th in the US – company side representation
- 16th in the US overall
- 18th in the US – investor side representation
- 14th in the world – company side representation
- 22nd in the world overall
- 8th in the world health care devices and supplies
- 10th in the world in commercial services
- 10th in the world in health care services and systems